Building early-stage brand recognition for an innovative miRNA liquid biopsy blood test aimed at early breast cancer detection.
The Situation
Preferred Medicine was looking to prepare its brand for generating interest with the investor community as the company looks to gainFDA approval. Their first product to market will be a novel miRNA liquid biopsy blood test will offer physicians a highly accurate early detection screen tool for women at risk for breast cancer.
ParkerWhite set out to build a fresh brand strategy to tell their compelling story of science, passion, and perseverance to develop life-changing technologies that will help detect cancer earlier and ultimately save lives.
What we did:
Stakeholder Interviews
Brand Workshop
Brand Messaging Platform
Product Logo Identity
UX + Visual Design
Website Programming
Brand Messaging Platform
As an output of our brand workshop, ParkerWhite crafted a compelling and succinct brand messaging platform to align all communications and team around a clear positioning strategy and story supported with inspiring company core values. It is all summed up in their new tagline: It’s in our blood.
Website Wireframes and Design
Our wireframe process allows us to walk our client through the user experience and content flow before moving into creative designs and outlining content needs. The design of the new website captured the passion of the company in their mission to catch cancers earlier while communicating the unique science in very simple to understand terms.
Product Logo Identity
We explored a variety of logo treatments to land on this clean and modern identity for its first breast cancer test.
Let's start a conversation
We partner with our clients to understand their business, people, and goals to provide practical solutions that deliver long-term success.
